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Background: Numerous studies have concluded that secondhand smoke (SHS) is harmful to non-smokers
but controversy persists regarding its effects on smokers. The impact of SHS exposure on the acute
respiratory health of current active smokers was examined using a cross sectional design.
Methods: 9923 uniformed staff in the Hong Kong Police Force completed a standardised questionnaire on
current and past smoking, SHS exposure at home and at work, acute respiratory symptoms, and recent
physician consultation. 3999 male current smokers were included in the analysis.
Results: About 5% of the smokers were exposed to SHS at home only, 53% were exposed at work only,
and 30% were exposed both at home and at work. The prevalence ratios for respiratory symptoms (throat
and nasal problems, cough, phlegm, and wheeze), physician consultation, and self medication were
higher for those who were exposed to SHS at home or at work. The odds ratios of reporting one or more
respiratory symptoms, for SHS exposures at home or at work, were 1.33 (95% confidence interval (CI)
1.12 to 1.59) and 1.66 (95% CI 1.36 to 2.02) respectively, after adjusting for age, marital status,
education, rank and duties, exposure to self perceived dusty or polluted environment in previous job, and
total dose of active smoking. The adjusted odds ratios showed significant positive dose–response gradients
with SHS exposure at home, at work, and at both places combined.
Conclusions: SHS exposure is strongly associated with increased acute respiratory symptoms and recent
outpatient service utilisation in current smokers. If the association is causal, public health action to limit SHS
exposure could also benefit smokers.
A
lthough secondhand smoke (SHS) or environmental
tobacco smoke has been shown to be a class 1 human
lung carcinogen1 and a causal factor for heart disease
in adults and respiratory ill health in both children and
adults,2 most of the evidence has been derived from studies
on non-smokers. Sidestream smoke is qualitatively different
from and more toxic than mainstream smoke.3 Few studies
have examined the adverse effects of SHS exposure among
active smokers, although smokers are at least equally if not
more exposed to SHS from other smokers nearby. Our
Medline search from January 1983 to October 2004 using the
criteria ‘‘passive or second-hand or second-hand or involun-
tary; smok$ or tobacco$ or cigarette$’’ and ‘‘active smoker$
or passive smoker$’’ ($ indicates one or more characters)
yielded only two reports on SHS and respiratory problems
among adult smokers. Both studies were from the USA and
neither demonstrated significant relationships.4 5 The objec-
tive of this study was to investigate the association between
SHS exposure in current active smokers and acute respiratory
health problems and related ambulatory service utilisation
during the previous two weeks.
METHODS
Subjects
A total of 11 038 uniformed officers in the traffic, foot patrol,
and marine formations of the Hong Kong Police Force were
invited to participate in a health survey commissioned by the
senior management of the force. During December 1995 to
January 1996, the subjects completed a self administered
structured questionnaire under classroom conditions. The
questionnaire covered demographic characteristics, history of
occupational exposure before their employment with the force,
smoking habits, exposure to SHS at home and at work, and
utilisation of ambulatory health care services in the previous 14
days. Respiratory symptoms were elicited using the UKMedical
Research Council respiratory health questionnaire.6 Completed
questionnaires were put into envelopes, sealed, and returned to
the investigators at the end of each session. The subjects were
reassured that no one, including their seniors and peers in the
force, other than designated researchers in the University
Department of Community Medicine, would be permitted
access to the identity of individual subjects and that confidenti-
ality was guaranteed. A total of 9923 officers participated with a
response rate of 90%, of whom 4102 were current smokers.
Because of the much lower prevalence (12.3%, n = 103) of
female smokers only the 3999 male current smokers were
included in this analysis. The data on 4468 male never-smokers
were also analysed and compared to the current smokers.
SHS exposure measurements and health outcomes
The dependent variables for respiratory symptoms are throat
problems, cough (or phlegm) in the morning, cough (or
phlegm) during day/night, chronic cough (or phlegm), any
cough or phlegm, increased cough and phlegm, ever
wheezing, blocked/running nose, and any respiratory symp-
toms. Utilisation of outpatient health services during the past
14 days was assessed by doctor consultation for respiratory
symptoms. The definitions of these variables have been
reported in the previous publication.7
A current smoker was defined as one who currently and
during the previous six months smoked at least one cigarette
a day (or one cigar a week or an ounce of tobacco a month).
Although our focus of investigation was the effects of SHS on
current active smokers, never-smokers were also analysed for
the purpose of comparison. Exposure to SHS at home was
defined by the presence of one or more smokers who lived in
the same household as the subject. Exposure to SHS at work
was defined by the presence of one or more co-workers who
smoked nearby in the same room each day.
Cigarette-hours is computed by multiplying the average
number of cigarettes smoked by co-workers per hour to
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which subjects were exposed in the workplace by eight hours,
which is the notional number of working hours per day.
Statistical analysis
In comparing the effects of SHS exposure at work and/or at
home, on respiratory symptoms, multivariable logistic regres-
sion was used to calculate odds ratios (OR) with 95%
confidence intervals (CI), adjusted for age, marital status,
educational attainment, police rank, type of duties (that is,
traffic police, foot patrol, or marine police), exposure to a self
perceived dusty or polluted environment in previous jobs, and
SHS exposure at home or at work. Additional adjustment for
amount of cigarette smoking (that is, 1–10, 11–20, 21–30,
> 30 cigarettes per day) and duration of smoking (that is,
, 5, 5 to , 10, 10 to , 15, 15+ years) was made in current
smokers, and also for smoking status in the analysis of
smokers and never-smokers combined. To examine further
whether or not the effects of SHS exposure in current
smokers and never-smokers were similar, interaction terms
for SHS exposure and smoking status (that is, current
smokers v never-smokers) were fitted in the logistic regres-
sion model. A significant interaction term indicated a
differential SHS effect. The analysis was performed using
STATA version 8.0.8
RESULTS
The analysis of never-smokers had been published pre-
viously7; only part of the results on never-smokers (that is,
SHS prevalence and adjusted odds ratios) were repeated in
tables 2–4.
The demographic characteristics and SHS exposure pat-
terns in current smokers are summarised in table 1. Only
12.5% were not exposed at home or at work and 5% were
exposed at home only. About half (53%) were exposed at
work only, and 30% were exposed at home and at work. One
third (33%) were exposed to four or more smoking co-
workers, indicating that work exposure was much heavier
than exposure at home where only 1.3% were exposed to four
or more smokers.
Smokers had higher prevalence ratios for respiratory symp-
toms than never-smokers regardless of SHS exposure, but
physician consultation and medication prevalence ratios were
similar (table 2). The prevalence ratios for most respiratory
symptoms were higher among those exposed to SHS at home,
with adjusted odds ratios reaching 1.33 (95% CI 1.12 to 1.59) for
any symptoms (table 2). For SHS exposure at work, all the odds
ratios for symptoms and physician consultation were highly
significant and higher than those for home exposure. The
highest, for chronic cough, was 2.52 (95% CI 1.54 to 4.13), and
for any symptoms, 1.66 (95% CI 1.36 to 2.02).
We found significant dose–response relationships between
all the outcome measures and the number of smokers at
work, except for nasal problems (table 3). For those who
were exposed to four or more smokers, the odds ratio for
chronic cough was 3.02 (95% CI 1.80 to 5.06). There were also
significant trends for all outcome measures with the daily
amount of exposure as stratified by cigarette-hours (table 4).
For SHS exposure at home, significant trends with the
number of smokers at home were found for eight out of the
15 outcome measures (table 5).
The adjusted odds ratios for the effects of SHS exposure on
current smokers were similar to those for never-smokers.
Moreover, most of the interaction terms for SHS exposure
variables and smoking status (that is, current smokers v
never-smokers) were not significant, indicating that the
magnitude of the effects of SHS exposure on current smokers
and never-smokers were similar.
To explore further the possibility of residual confounding
in smokers due to their daily cigarette consumption, the
Table 1 Demographic characteristics and secondhand
smoke (SHS) exposure in 3999 male current smokers in
the Hong Kong Police
Characteristics No. %
Age (years)
(24 844 21.1
25–29 1059 26.5
30–34 789 19.8
35–39 575 14.4
>40 724 18.1
Marital status
Single 1796 45.3
Married 2054 51.8
Other 113 2.9
Educational attainment
Grade 10 or below 809 20.8
Grade 11 2891 74.5
Grades 12–13 139 3.6
Post-secondary 43 1.1
Police rank
Police constable 3248 81.6
Sergeant or senior sergeant 638 16.0
Inspector or above 96 2.4
Type of police
Traffic police 548 13.8
Foot patrol 2767 69.5
Marine police 664 16.7
Worked in self perceived dusty or polluted
environment before
No 3417 86.7
Yes 526 13.3
Daily amount of cigarette consumption (cigarettes)
1–10 1058 27.4
11–20 1940 50.2
21–30 331 8.6
.30 538 13.9
Duration of cigarette smoking (years)
,5 681 17.4
5 to ,10 1170 29.8
10 to ,15 920 23.4
15+ 1155 29.4
SHS exposure*
None 482 12.5
At home only 194 5.0
At work only 2047 52.9
At home and at work 1146 29.6
Total number of smokers at home and at work
0 482 12.6
1 446 11.6
2–3 1291 33.7
4–5 695 18.1
>6 921 24.0
Number of co-workers smoking nearby at work
0 688 17.7
1 475 12.2
2 662 17.0
3 769 19.8
>4 1294 33.3
Number of smokers at home
0 2559 65.3
1 949 24.2
2 268 6.8
3 90 2.3
>4 50 1.3
Daily amount of SHS exposure at work, number of
cigarette-hours`
0 688 17.6
(4 789 20.2
4–16 767 19.6
.16–48 793 20.3
.48 873 22.3
Missing data were excluded.
*Excluding self-exposure.
Excluding self.
`Cigarette-hours were calculated by multiplying the average number of
cigarettes smoked by co-workers per hour to which subjects were
exposed in the workplace by 8 hours, which is the notional number of
working hours per day.
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analysis was stratified by daily smoking amount (that is,
1–10, 11–20, and . 30 cigarettes) (results not shown in the
tables). Strong and consistent effects of SHS were still
observed, with all significant odds ratios being greater than
unity in the three categories of smokers (see appendix: to
view appendix visit the Tobacco Control website—http://
www.tobaccocontrol.com/supplemental).
DISCUSSION
In a probability sample survey of nine neighbourhoods in
Philadelphia, Dayal et al4 did not find that greater SHS
exposure (( 1 pack/day v . 1 pack/day) was associated with
more obstructive respiratory conditions among current
smokers. The researchers did not allow for a category of no
SHS exposure because all smokers were assumed to be
Table 2 Adjusted odds ratios for respiratory symptoms and physician consultations by source of secondhand smoke
exposures in males
Prevalence (%)
SHS at home SHS at work Odds ratio (95% CI)
No
(n = 2559)
Yes
(n = 1357) p Value
No
(n = 688)
Yes
(n = 3222) p Value SHS at home SHS at work
Throat problems
Current smokers 37.7 42.4 0.005 29.3 41.4 ,0.001 1.14 (0.98 to 1.33) 1.62*** (1.32 to 1.97)
Never-smokers 32.4 31.6 0.62 20.6 35.4 ,0.001 0.99 (0.82 to 1.18) 2.15*** (1.77 to 2.61)
p for interaction1 ,0.05 0.115
Cough, morning
Current smokers 26.7 31.2 0.003 19.2 30.2 ,0.001 1.15 (0.97 to 1.37) 1.76*** (1.40 to 2.21)
Never-smokers 14.7 16.5 0.20 10.4 16.6 ,0.001 1.15 (0.92 to 1.45) 1.72*** (1.33 to 2.21)
p for interaction 0.490 0.577
Cough, day or night
Current smokers 24.1 29.9 ,0.001 16.9 27.9 ,0.001 1.27** (1.07 to 1.51) 1.80*** (1.42 to 2.28)
Never-smokers 14.4 15.9 0.26 9.6 16.2 ,0.001 1.16 (0.92 to 1.46) 1.81*** (1.39 to 2.34)
p for interaction 0.157 0.726
Cough, chronic
Current smokers 6.8 7.8 0.205 3.4 7.9 ,0.001 1.11 (0.83 to 1.48) 2.52*** (1.54 to 4.13)
Never-smokers 4.0 4.1 0.94 2.0 4.7 ,0.001 1.03 (0.68 to 1.56) 2.61** (1.50 to 4.55)
p for interaction 0.551 0.978
Phlegm, morning
Current smokers 36.6 39.9 0.049 29.4 39.6 ,0.001 1.24** (1.06 to 1.45) 1.33** (1.09 to 1.62)
Never-smokers 20.2 19.7 0.73 12.8 22.3 ,0.001 1.08 (0.88 to 1.34) 1.92*** (1.52 to 2.42)
p for interaction 0.159 0.087
Phlegm, day or night
Current smokers 26.6 30.6 0.009 19.3 29.8 ,0.001 1.24* (1.05 to 1.47) 1.62*** (1.30 to 2.04)
Never-smokers 14.1 14.2 0.94 8.3 15.8 ,0.001 1.07 (0.84 to 1.37) 2.03*** (1.53 to 2.67)
p for interaction 0.098 0.500
Phlegm, chronic
Current smokers 12.2 12.6 0.684 7.8 13.4 ,0.001 1.07 (0.85 to 1.34) 1.67** (1.21 to 2.31)
Never-smokers 5.9 6.7 0.42 3.5 6.8 ,0.001 1.29 (0.91 to 1.82) 2.05** (1.35 to 3.11)
p for interaction 0.727 0.512
Any cough or phlegm
Current smokers 48.3 53.8 ,0.001 38.7 52.7 ,0.001 1.23** (1.05 to 1.43) 1.56*** (1.30 to 1.89)
Never-smokers 30.1 30.7 0.74 20.6 33.0 ,0.001 1.10 (0.92 to 1.32) 1.87*** (1.54 to 2.26)
p for interaction 0.117 0.536
Increased cough or phlegm
Current smokers 22.2 25.0 0.048 14.8 25.0 ,0.001 1.06 (0.88 to 1.27) 1.81*** (1.41 to 2.32)
Never-smokers 16.0 18.2 0.11 10.1 18.1 ,0.001 1.12 (0.90 to 1.39) 1.88*** (1.47 to 2.41)
p for interaction 0.983 0.729
Ever wheezing
Current smokers 11.0 15.0 ,0.001 9.8 13.0 0.022 1.18 (0.94 to 1.47) 1.37* (1.01 to 1.87)
Never-smokers 7.8 11.7 ,0.001 5.5 9.4 ,0.001 1.41* (1.08 to 1.85) 1.76** (1.26 to 2.45)
p for interaction 0.614 0.381
Blocked or running nose
Current smokers 34.3 42.8 ,0.001 31.7 38.6 ,0.001 1.19* (1.02 to 1.39) 1.28* (1.05 to 1.55)
Never-smokers 32.1 38.1 ,0.001 23.1 36.1 ,0.001 1.15 (0.97 to 1.37) 1.85*** (1.54 to 2.23)
p for interaction 0.382 ,0.01
Any symptoms above
Current smokers 69.1 76.8 ,0.001 60.6 74.1 ,0.001 1.33** (1.12 to 1.59) 1.66*** (1.36 to 2.02)
Never-smokers 57.0 62.2 0.007 42.1 62.5 ,0.001 1.15 (0.96 to 1.37) 2.33*** (1.97 to 2.75)
p for interaction 0.154 ,0.05
Physician consultations in past 14 days` for respiratory symptoms
Current smokers 17.0 16.5 0.702 12.1 17.8 0.000 1.02 (0.83 to 1.25) 1.48** (1.13 to 1.93)
Never-smokers 19.2 17.8 0.34 15.6 20.1 0.003 1.13 (0.91 to 1.40) 1.30* (1.05 to 1.61)
p for interaction 0.606 0.245
*p,0.05; **p,0.01; ***p,0.001.
Odds ratios are adjusted for age, marital status, educational attainment, police rank, type of police duties, exposure to self perceived dusty or polluted
environment in previous job, and other SHS exposure. Additional adjustment for amount of smoking and duration of smoking was made in current smokers, and
for smoking status in the analysis of current smokers and never-smokers combined.
`Western physicians and Chinese traditional doctors
1p for interaction for SHS exposure variables and smoking status. A significant p value indicates significant difference in odds ratios between current smokers and
never-smokers.
Odds ratios, adjusted for the variables above, except for SHS, for the top 12 items of respiratory symptoms in all current versus all never-smokers ranged from
1.09 (95% CI 0.99 to 1.20) for blocked nose to 2.50 (95% CI 2.25 to 2.78) for morning phlegm. The details are not shown here but are available from the authors.
Adjusted odds ratio for the bottom three items were near unity (p.0.05).
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exposed to SHS. In addition, the prevalence estimates in the
report were not adjusted for potential confounders. On the
other hand, from the National Health Interview Survey,
Mannino et al5 reported that US current smokers with SHS
exposure at home or at work (defined using dichotomised
measures) were more likely to have reported an exacerbation
of chronic respiratory disease in the two weeks preceding the
survey than those not exposed to SHS, but the differences
were not significant. A possible reason for the null or non-
significant positive findings in the two studies may be due to
the fairly crude way of measuring and defining SHS exposure
using dichotomous variables. In contrast, we used the
number of workers smoking nearby and the amount they
smoked to quantify SHS exposure more sensitively. With a
more accurate SHS exposure proxy allowing more precise
measurement of risk, we had greater statistical power to
detect the excess risk.
Eisner et al9 investigated the effect of SHS exposure on
respiratory health before and after legislative prohibition of
smoking in all bars and taverns by the state of California.
During the follow up period, no overall change in daily
cigarette consumption was observed in the current smoking
bartenders. Of these, 63% of the symptomatic smokers no
longer reported any respiratory symptoms after prohibition of
smoking in their workplaces. This natural experiment has
provided indirect evidence that the SHS exposure can
Table 3 Adjusted odds ratios for respiratory symptoms and physician consultations by number of smokers at work in males
1 smoker OR (95% CI) 2 smokers OR (95% CI) 3 smokers OR (95% CI) >4 smokers OR (95% CI)
p for linear
trend
Throat problems
Current smokers 1.52** (1.16 to 1.99) 1.53*** (1.19 to 1.97) 1.63*** (1.28 to 2.07) 1.73*** (1.39 to 2.16) ,0.001
Never-smokers 1.48** (1.12 to 1.96) 1.98*** (1.56 to 2.51) 2.08*** (1.64 to 2.62) 2.62*** (2.12 to 3.24) ,0.001
p for interaction1 0.702 0.203 0.393 ,0.05
Cough, morning
Current smokers 1.37* (1.01 to 1.87) 1.63*** (1.23 to 2.16) 1.73*** (1.32 to 2.27) 2.03*** (1.58 to 2.61) ,0.001
Never-smokers 1.55* (1.08 to 2.22) 1.78*** (1.31 to 2.43) 1.69** (1.24 to 2.29) 1.76*** (1.32 to 2.33) ,0.001
p for interaction 0.743 0.639 0.599 0.294
Cough, day or night
Current smokers 1.40* (1.02 to 1.93) 1.66*** (1.24 to 2.23) 1.84*** (1.39 to 2.43) 2.03*** (1.57 to 2.63) ,0.001
Never-smokers 1.46* (1.01 to 2.11) 1.77*** (1.29 to 2.43) 1.74*** (1.27 to 2.37) 1.99*** (1.50 to 2.65) ,0.001
p for interaction 0.927 0.893 0.536 0.679
Cough, chronic
Current smokers 2.26** (1.24 to 4.15) 1.90* (1.06 to 3.42) 2.45** (1.41 to 4.26) 3.02*** (1.80 to 5.06) ,0.001
Never-smokers 2.10* (1.01 to 4.37) 2.22* (1.16 to 4.27) 2.62** (1.40 to 4.92) 3.02*** (1.68 to 5.44) ,0.001
p for interaction 0.790 0.845 0.939 0.850
Phlegm, morning
Current smokers 1.12 (0.85 to 1.47) 1.26 (0.98 to 1.61) 1.28* (1.01 to 1.63) 1.47*** (1.18 to 1.83) ,0.001
Never-smokers 1.36 (0.97 to 1.91) 1.91*** (1.44 to 2.53) 1.94*** (1.47 to 2.55) 2.15*** (1.67 to 2.77) ,0.001
p for interaction 0.549 0.058 0.067 0.070
Phlegm, day or night
Current smokers 1.43* (1.06 to 1.94) 1.71*** (1.29 to 2.25) 1.65*** (1.26 to 2.16) 1.64*** (1.28 to 2.10) ,0.001
Never-smokers 1.25 (0.83 to 1.89) 1.93*** (1.38 to 2.69) 1.93*** (1.39 to 2.68) 2.47*** (1.83 to 3.34) ,0.001
p for interaction 0.471 0.780 0.715 0.105
Phlegm, chronic
Current smokers 1.27 (0.82 to 1.98) 1.48 (0.99 to 2.19) 1.48* (1.01 to 2.16) 2.04*** (1.44 to 2.88) ,0.001
Never-smokers 0.89 (0.45 to 1.75) 2.01** (1.23 to 3.29) 1.60 (0.97 to 2.65) 2.83*** (1.82 to 4.40) ,0.001
p for interaction 0.382 0.342 0.831 0.327
Any cough or phlegm
Current smokers 1.27 (0.98 to 1.65) 1.54*** (1.21 to 1.96) 1.58*** (1.25 to 1.98) 1.69*** (1.37 to 2.09) ,0.001
Never-smokers 1.34* (1.01 to 1.77) 1.92*** (1.51 to 2.43) 1.80*** (1.43 to 2.28) 2.09*** (1.69 to 2.59) ,0.001
p for interaction 0.983 0.339 0.718 0.344
Increased cough or phlegm
Current smokers 1.53* (1.09 to 2.13) 1.71*** (1.26 to 2.32) 1.78*** (1.32 to 2.39) 1.96*** (1.49 to 2.57) ,0.001
Never-smokers 1.56* (1.10 to 2.21) 1.57** (1.15 to 2.13) 1.95*** (1.45 to 2.62) 2.18*** (1.67 to 2.85) ,0.001
p for interaction 0.804 0.356 0.902 0.993
Ever wheezing
Current smokers 1.29 (0.86 to 1.96) 1.24 (0.84 to 1.82) 1.26 (0.87 to 1.83) 1.53* (1.09 to 2.13) ,0.05
Never-smokers 1.58 (0.99 to 2.51) 1.66* (1.10 to 2.50) 1.97** (1.33 to 2.91) 1.74** (1.21 to 2.51) ,0.01
p for interaction 0.380 0.414 0.139 0.651
Blocked or running nose
Current smokers 1.32* (1.01 to 1.72) 1.44** (1.13 to 1.84) 1.22 (0.96 to 1.54) 1.21 (0.98 to 1.51) 0.340
Never-smokers 1.51** (1.15 to 1.98) 1.75*** (1.39 to 2.21) 1.82*** (1.45 to 2.29) 2.07*** (1.69 to 2.55) ,0.001
p for interaction 0.450 0.236 ,0.05 ,0.001
Any symptoms above
Current smokers 1.48** (1.12 to 1.96) 1.76*** (1.35 to 2.29) 1.58*** (1.23 to 2.02) 1.73*** (1.38 to 2.17) ,0.001
Never-smokers 1.79*** (1.39 to 2.30) 2.17*** (1.75 to 2.70) 2.28*** (1.84 to 2.82) 2.73*** (2.25 to 3.31) ,0.001
p for interaction 0.353 0.384 0.096 ,0.05
Physician consultations in past 14 days for respiratory symptoms`
Current smokers 1.55* (1.09 to 2.20) 1.48* (1.06 to 2.05) 1.48* (1.08 to 2.03) 1.47** (1.10 to 1.98) 0.051
Never-smokers 1.13 (0.82 to 1.56) 1.17 (0.89 to 1.53) 1.32* (1.01 to 1.72) 1.41** (1.11 to 1.80) ,0.01
p for interaction 0.123 0.189 0.412 0.489
*p,0.05; **p,0.01; ***p,0.001.
Within each smoking category, the reference group is current smokers with no co-workers smoking nearby at work; odds ratios are adjusted for age, marital
status, educational attainment, police rank, type of police duties, exposure to self perceived dusty or polluted environment in previous job, and SHS exposure at
home. Additional adjustment for amount of smoking and duration of smoking was made in current smokers, and for smoking status in the analysis of current
smokers and never-smokers combined.
`Western physicians and Chinese traditional doctors
1p for interaction for SHS exposure variables and smoking status. A significant p value indicates significant difference in odds ratios between current smokers and
never-smokers.
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produce an adverse impact on respiratory health in current
smokers. However, no dose response gradient was examined
in that study.
Our study is the first to show strong and significant dose–
response relationships between SHS exposure at home and at
work and acute and chronic respiratory symptoms, and
physician consultation. It is biologically plausible that SHS
can cause respiratory symptoms in active smokers as it causes
such symptoms in non-smokers. There could be several
reasons why previous studies did not find significant
relationships. First, many studies on SHS were focused on
non-smokers and the smokers were not asked about their
SHS exposure. Second, the effects of active smoking may
have been very strong and the level of SHS exposures either
proportionately relatively low or not uniform across all
subjects, so that the effects of SHS could not be separated
from those of active smoking. Third, as smoke-free policies
have become more common in western countries with more
stringent tobacco control measures, fewer people smoke in
the workplace and we would expect smokers to be less
exposed to SHS from their co-workers, whereas Hong Kong
has yet to outlaw smoking in the workplace, including
Table 4 Adjusted odds ratios for respiratory symptoms and physician consultations by daily amount of SHS exposure
(cigarette-hours) at work in males
(4 cigarette-hours OR
(95% CI)
.4 to 16 cigarette-hours
OR (95% CI)
.16 to 48 cigarette-hours
OR (95% CI)
.48 cigarette-hours
OR (95% CI)
p for linear
trend
Throat problems
Current smokers 1.38** (1.08 to 1.75) 1.39** (1.09 to 1.77) 1.96*** (1.55 to 2.49) 1.79*** (1.41 to 2.28) ,0.001
Never-smokers 1.53*** (1.21 to 1.92) 2.04*** (1.62 to 2.57) 2.62*** (2.07 to 3.32) 2.79*** (2.21 to 3.53) ,0.001
p for interaction1 0.675 0.099 0.245 ,0.05
Cough, morning
Current smokers 1.32 (1.00 to 1.74) 1.69*** (1.29 to 2.22) 2.02*** (1.55 to 2.64) 2.06*** (1.57 to 2.69) ,0.001
Never-smokers 1.17 (0.85 to 1.59) 1.72*** (1.27 to 2.33) 2.12*** (1.56 to 2.87) 2.10*** (1.55 to 2.85) ,0.001
p for interaction 0.608 0.806 0.878 0.793
Cough, day or night
Current smokers 1.24 (0.93 to 1.66) 1.70*** (1.28 to 2.25) 2.21*** (1.68 to 2.91) 2.14*** (1.62 to 2.82) ,0.001
Never-smokers 1.21 (0.88 to 1.67) 1.84*** (1.35 to 2.49) 2.20*** (1.61 to 2.99) 2.24*** (1.65 to 3.04) ,0.001
p for interaction 0.881 0.977 0.716 0.812
Cough, chronic
Current smokers 1.86* (1.04 to 3.30) 1.82* (1.02 to 3.23) 2.76*** (1.60 to 4.75) 3.69*** (2.16 to 6.30) ,0.001
Never-smokers 1.45 (0.74 to 2.83) 2.76*** (1.48 to 5.13) 3.06*** (1.63 to 5.74) 3.58*** (1.93 to 6.61) ,0.001
p for interaction 0.519 0.339 0.931 0.698
Phlegm, morning
Current smokers 1.00 (0.79 to 1.28) 1.19 (0.94 to 1.52) 1.52*** (1.20 to 1.93) 1.66*** (1.31 to 2.11) ,0.001
Never-smokers 1.27 (0.95 to 1.68) 1.73*** (1.31 to 2.28) 2.23*** (1.69 to 2.95) 2.83*** (2.16 to 3.71) ,0.001
p for interaction 0.216 0.086 0.092 ,0.05
Phlegm, day or night
Current smokers 1.10 (0.83 to 1.46) 1.80*** (1.38 to 2.35) 1.75*** (1.34 to 2.28) 1.94*** (1.49 to 2.53) ,0.001
Never-smokers 1.42* (1.02 to 1.98) 1.83*** (1.32 to 2.54) 2.38*** (1.71 to 3.30) 2.77*** (2.01 to 3.82) ,0.001
p for interaction 0.303 0.885 0.271 0.304
Phlegm, chronic
Current smokers 1.26 (0.85 to 1.87) 1.56* (1.07 to 2.29) 1.62* (1.11 to 2.36) 2.24*** (1.56 to 3.22) ,0.001
Never-smokers 1.09 (0.65 to 1.85) 1.58 (0.96 to 2.60) 2.64*** (1.63 to 4.26) 3.38*** (2.13 to 5.38) ,0.001
p for interaction 0.740 0.864 0.123 0.372
Any cough or phlegm
Current smokers 1.14 (0.90 to 1.43) 1.60*** (1.27 to 2.01) 1.76*** (1.40 to 2.21) 1.89*** (1.50 to 2.38) ,0.001
Never-smokers 1.24 (0.98 to 1.56) 1.77*** (1.40 to 2.23) 2.35*** (1.85 to 2.98) 2.52*** (1.99 to 3.18) ,0.001
p for interaction 0.625 0.885 0.184 0.314
Increased cough or phlegm
Current smokers 1.48* (1.10 to 2.00) 1.77*** (1.31 to 2.38) 1.99*** (1.49 to 2.66) 2.00*** (1.50 to 2.68) ,0.001
Never-smokers 1.34 (0.99 to 1.80) 1.92*** (1.44 to 2.57) 2.35*** (1.75 to 3.15) 2.17*** (1.62 to 2.92) ,0.001
p for interaction 0.441 0.896 0.752 0.574
Ever wheezing
Current smokers 1.16 (0.80 to 1.69) 1.28 (0.89 to 1.86) 1.41 (0.98 to 2.02) 1.66** (1.16 to 2.37) ,0.01
Never-smokers 1.28 (0.85 to 1.91) 1.62* (1.09 to 2.41) 2.33*** (1.58 to 3.43) 1.98*** (1.34 to 2.93) ,0.001
p for interaction 0.711 0.467 0.057 0.589
Blocked or running nose
Current smokers 1.31* (1.04 to 1.66) 1.07 (0.84 to 1.35) 1.43** (1.13 to 1.80) 1.32* (1.04 to 1.67) ,0.05
Never-smokers 1.53*** (1.23 to 1.91) 1.81*** (1.44 to 2.26) 1.92*** (1.53 to 2.42) 2.30*** (1.83 to 2.89) ,0.001
p for interaction 0.218 ,0.01 0.060 ,0.01
Any symptoms above
Current smokers 1.41** (1.11 to 1.80) 1.55*** (1.21 to 1.98) 1.92*** (1.49 to 2.47) 1.85*** (1.43 to 2.38) ,0.001
Never-smokers 1.68*** (1.37 to 2.06) 2.25*** (1.82 to 2.78) 2.74*** (2.19 to 3.42) 3.16*** (2.53 to 3.95) ,0.001
p for interaction 0.186 0.094 0.080 ,0.05
Physician consultations in past 14 days for respiratory symptoms`
Current smokers 1.51** (1.10 to 2.07) 1.36 (0.98 to 1.88) 1.53** (1.12 to 2.10) 1.51** (1.10 to 2.07) ,0.05
Never-smokers 1.08 (0.83 to 1.41) 1.21 (0.93 to 1.58) 1.43** (1.09 to 1.87) 1.55*** (1.19 to 2.01) ,0.001
p for interaction 0.061 0.540 0.290 0.803
*p,0.05; **p,0.01; ***p,0.001.
Within each smoking category, the reference group is current smokers without SHS exposure nearby at work; odds ratios are adjusted for age, marital status,
educational attainment, police rank, type of police duties, exposure to self perceived dusty or polluted environment in previous job, and SHS exposure at home.
Additional adjustment for amount of smoking and duration of smoking was made in current smokers, and for smoking status in the analysis of current smokers and
never-smokers combined.
`Western physicians and Chinese traditional doctors.
1p for interaction for SHS exposure variables and smoking status. A significant p value indicates significant difference in odds ratios between current smokers and
never-smokers.
Cigarette-hours were calculated by multiplying exposure to average number of cigarettes smoked by co-workers nearby in one hour with 8 hours per day.
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restaurants, bars and other public places. Fourth, if smokers
are less aware of their SHS exposures, they might have
under-reported exposure.
Among current smokers, all are in fact exposed to SHS. The
distinction lies between exposure to smoke from their own
cigarettes and smoke from other smokers’ cigarettes.
Although it is difficult to imagine in the real world any
smoker not being exposed to smoke emitted from his or her
cigarettes in between puffs, our calculation of the odds ratio
of SHS in smokers was based on comparing the odds of
respiratory symptoms who were not exposed to others’ SHS
with those who were, the amount of which depends on the
number of smokers in the vicinity. Therefore our comparisons
in respiratory symptoms were between ‘‘some exposure’’ (the
reference category) and ‘‘greater amounts’’ (depending on
numbers of smokers in the vicinity). SHS from smokers’ own
cigarettes may be qualitatively different from that caused by
other peoples’ smoking due to settling and aging of the
smoke as it disperses. As a result, the true strength of
association may be even greater than that reported.
The strength of the present study is that we used the same
standardised structured questionnaire and asked the same
questions on SHS exposure of all police officers, regardless of
their smoking status. We asked objective questions on the
number of smokers smoking at home and the number of co-
workers who smoked nearby, and avoided the subjective
Table 5 Adjusted odds ratios for respiratory symptoms and physician consultations by number of smokers at home in males
1 smoker
OR (95% CI)
2 smokers
OR (95% CI)
3 smokers
OR (95% CI)
>4 smokers
OR (95% CI)
p for linear
trend
Throat problems
Current smokers 1.09 (0.92 to 1.30) 1.32 (0.99 to 1.75) 1.02 (0.62 to 1.67) 1.53 (0.82 to 2.86) 0.053
Never-smokers 0.97 (0.79 to 1.20) 0.82 (0.56 to 1.21) 1.44 (0.84 to 2.47) 1.16 (0.60 to 2.25) 0.739
p for interaction1 0.087 ,0.05 0.629 0.425
Cough, morning
Current smokers 1.10 (0.92 to 1.33) 1.25 (0.92 to 1.71) 0.99 (0.57 to 1.70) 2.18* (1.16 to 4.09) ,0.05
Never-smokers 1.02 (0.78 to 1.34) 1.28 (0.81 to 2.00) 2.18* (1.20 to 3.96) 1.15 (0.50 to 2.65) 0.052
p for interaction 0.360 0.785 0.085 0.170
Cough, day or night
Current smokers 1.14 (0.95 to 1.38) 1.54** (1.13 to 2.09) 1.45 (0.85 to 2.46) 2.78*** (1.49 to 5.21) ,0.001
Never-smokers 1.08 (0.82 to 1.41) 1.25 (0.79 to 1.97) 1.94* (1.04 to 3.61) 1.02 (0.42 to 2.46) 0.101
p for interaction 0.400 0.261 0.648 ,0.05
Cough, chronic
Current smokers 1.05 (0.76 to 1.45) 1.08 (0.64 to 1.85) 1.18 (0.49 to 2.83) 2.39* (1.02 to 5.61) 0.151
Never-smokers 0.77 (0.45 to 1.31) 1.19 (0.53 to 2.65) 2.63* (1.09 to 6.36) 1.73 (0.52 to 5.76) 0.152
p for interaction 0.283 0.972 0.293 0.494
Phlegm, morning
Current smokers 1.17 (0.98 to 1.40) 1.47** (1.10 to 1.96) 1.44 (0.88 to 2.37) 1.19 (0.63 to 2.25) ,0.01
Never-smokers 1.09 (0.85 to 1.39) 0.92 (0.58 to 1.46) 1.54 (0.84 to 2.83) 0.97 (0.44 to 2.16) 0.476
p for interaction 0.430 0.062 0.972 0.475
Phlegm, day or night
Current smokers 1.19 (0.99 to 1.43) 1.36 (1.00 to 1.84) 1.64 (0.98 to 2.74) 1.17 (0.59 to 2.31) ,0.01
Never-smokers 0.99 (0.75 to 1.32) 0.87 (0.50 to 1.49) 2.07* (1.11 to 3.86) 1.53 (0.69 to 3.40) 0.145
p for interaction 0.105 0.086 0.725 0.896
Phlegm, chronic
Current smokers 1.08 (0.84 to 1.38) 1.04 (0.68 to 1.60) 0.91 (0.43 to 1.97) 1.19 (0.51 to 2.78) 0.704
Never-smokers 1.09 (0.72 to 1.67) 1.52 (0.77 to 3.01) 2.16 (0.90 to 5.19) 1.80 (0.62 to 5.21) ,0.05
p for interaction 0.599 0.692 0.337 0.794
Any cough or phlegm
Current smokers 1.18 (0.99 to 1.40) 1.39* (1.05 to 1.85) 1.18 (0.72 to 1.93) 1.53 (0.80 to 2.89) ,0.01
Never-smokers 1.08 (0.88 to 1.34) 1.08 (0.74 to 1.58) 1.50 (0.87 to 2.60) 0.87 (0.42 to 1.78) 0.348
p for interaction 0.266 0.183 0.675 0.150
Increased cough or phlegm
Current smokers 1.04 (0.85 to 1.27) 1.10 (0.79 to 1.53) 0.72 (0.38 to 1.35) 1.84 (0.96 to 3.51) 0.365
Never-smokers 1.11 (0.86 to 1.42) 1.13 (0.73 to 1.76) 1.03 (0.51 to 2.08) 1.35 (0.61 to 3.00) 0.324
p for interaction 0.780 0.869 0.616 0.398
Ever wheezing
Current smokers 1.13 (0.88 to 1.45) 1.35 (0.92 to 1.98) 1.22 (0.62 to 2.38) 1.15 (0.47 to 2.79) 0.149
Never-smokers 1.31 (0.96 to 1.80) 1.84* (1.13 to 3.00) 1.44 (0.64 to 3.25) 1.25 (0.44 to 3.57) ,0.05
p for interaction 0.752 0.468 0.708 0.922
Blocked or running nose
Current smokers 1.20* (1.02 to 1.43) 1.38* (1.04 to 1.83) 0.73 (0.44 to 1.21) 1.01 (0.53 to 1.90) 0.212
Never-smokers 1.12 (0.92 to 1.37) 1.00 (0.70 to 1.44) 1.31 (0.76 to 2.25) 2.02* (1.07 to 3.83) ,0.05
p for interaction 0.375 0.113 0.124 0.183
Any symptoms above
Current smokers 1.36** (1.12 to 1.66) 1.29 (0.93 to 1.80) 1.19 (0.67 to 2.10) 1.25 (0.60 to 2.60) ,0.05
Never-smokers 1.14 (0.93 to 1.40) 1.07 (0.75 to 1.54) 1.18 (0.66 to 2.08) 1.51 (0.73 to 3.10) 0.128
p for interaction 0.184 0.381 0.990 0.949
Physician consultations in past 14 days for respiratory symptoms`
Current smokers 0.89 (0.71 to 1.12) 1.39 (0.97 to 1.97) 1.19 (0.64 to 2.22) 1.77 (0.87 to 3.58) 0.106
Never-smokers 1.16 (0.90 to 1.49) 0.95 (0.59 to 1.54) 0.92 (0.44 to 1.89) 2.17* (1.10 to 4.26) 0.128
p for interaction 0.165 0.154 0.405 0.648
*p,0.05; **p,0.01; ***p,0.001.
Within each smoking category, the reference group is current smokers with no smoker at home; odds ratios are adjusted for age, marital status, educational
attainment, police rank, type of police duties, exposure to self perceived dusty or polluted environment in previous job, and SHS exposure at work. Additional
adjustment for amount of smoking and duration of smoking was made in current smokers, and for smoking status in the analysis of current smokers and never-
smokers combined.
`Western physicians and Chinese traditional doctors
1p for interaction for SHS exposure variables and smoking status. A significant p value indicates the significant difference in odds ratios between current smokers
and never-smokers.
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interpretation of what constituted SHS exposure. In our
previous report we demonstrated strong dose–response
relationships between SHS and respiratory symptoms in
never smokers.7 Similar dose–response gradients were also
observed in active smokers in the present study.
Furthermore, we found that the adjusted odds ratios in
current smokers were similar to those in never smokers, as
shown by the insignificant interaction terms for SHS
exposure variables and smoking status. The similar effect
size of SHS in both never and current smokers lends support
to the validity of SHS measurement in our study.
In Hong Kong, as in mainland China and other countries in
Asia, smoking is allowed in many workplaces and SHS
exposure levels are higher than those in the USA and other
western countries. In the workforce we studied (the Hong
Kong Police), both smoking prevalence and SHS exposures
among smokers were much higher than in the general
population and provided a unique opportunity for the present
enquiry to examine dose–response relationships.
Although misclassification of smokers as non-smokers has
been used as an explanation for the observed association
between SHS exposure and adverse health effects in non-
smokers, misclassification of non-smokers as smokers is very
unlikely. We measured exhaled air carbon monoxide levels in a
random sample of 110 male officers and found that 50 of 55
declared smokers had values . 10 ppm, but no subjects who
declared they were non-smokers had values . 9 ppm. This
suggested that reporting of smoking status among police
officers was highly accurate and reliable. However, we
acknowledge that our study could have been strengthened by
more comprehensively and systematically validating SHS
exposure status and intensity using biochemical measures, in
addition to self reports. This, however, would be very difficult to
distinguish from metabolites resulting from active smoking,
unless radioactive traces were to be applied to the cigarettes
smoked by the subjects (v non-radioactive labelled SHS) under
trial conditions which would be prohibitively expensive and
impractical. More realistically, environmental measures such as
air nicotine levels in the workplace may be the best proxy
feasible for future studies to confirm the present observations.10
The questions used for eliciting respiratory symptoms also
appear to be valid. The odds ratios for all outcomes measures,
except for nasal problem (p = 0.26) and physician consulta-
tion for respiratory symptoms (p = 0.20), were expectedly
higher in current smokers than in non-smokers (table 2;
p value not shown). The adjusted odds ratios of respiratory
symptoms in current smokers versus never-smokers, regard-
less of SHS exposure, ranged from 1.09 to 2.50 (table not
shown), and were consistent with those from previous
reports, all of which ignored SHS exposure. These suggest
that although current smokers had poorer respiratory health
than the non-smokers, the former did not necessarily use
more health service, which is consistent with the pattern of
health service utilisation in smokers reported elsewhere.11 12
Smokers with respiratory symptoms may over-report SHS
exposures but we believe this is also unlikely because awareness
of the adverse effects of SHS among smokers was low (and
much lower than the non-smokers) and very few smokers, if
any, would have thought that their respiratory symptoms could
be attributed to other people’s smoking. The Dublin Healthy
Cities project13 shows that smokers were less likely than non-
smokers to be bothered by SHS exposure (50% v 92%) and be
aware that it was harmful to their health (59% v 85%).
Knowledge about health risks of SHS was also lower in the
Hong Kong general population.14 We also adjusted the risk
estimates for the amount smoked by the smokers themselves as
well as the total duration of smoking.
We acknowledge that the cross sectional design may first
appear to be a potential limitation of this survey but a reverse
causal association, that of increasing respiratory symptoms
leading to increasing SHS exposure, is highly doubtful,
especially given our focus on acute respiratory symptoms and
associated health services use in the previous 14 days. In fact,
we believe that a cross sectional design is probably the only
feasible and appropriate strategy in examining the acute
harmful effects of SHS where a two week window would not
be expected to induce an appreciable recall bias, and certainly
not a systematic one. On the other hand, random misclassi-
fication would only have diluted the observed results. In
addition, the strength of the relationship could have been
underestimated because smokers who were less vulnerable to
SHS could have survived in this work force which demands a
high level of physical fitness. Moreover, given the high
prevalence of smoking it is very likely that those who
reported no exposure and were used as the reference group
for odds ratio estimation could have been exposed and hence
misclassified, resulting in underestimation of the risk.
Residual confounding by some unknown factors cannot be
totally ruled out despite our adjustment of many potential
confounders, but it is difficult to conceive a confounder which
can explain away the strong dose response relationships here.
There were no designated smoking or smoke-free areas
with adequate enforcement, in the offices, transportation, or
leisure areas used by the workforce in the present study. With
a smoking prevalence of 28% among office workers in the
USA, Repace et al10 estimated that 95% of non-smoking
workers exceeded the level of 0.04 ng/ml of salivary cotinine,
corresponding to one expected death from heart disease per
1000 workers at risk from passive smoking.10 This corresponds
to the US Occupational Safety and Health Administration
significant risk level. Virtually all workers in office workplaces
with unrestricted smoking were estimated to exceed the de
manifestis (1 expected death per 8000 exposed) level.
If the association we observed here is causal, the current
focus on the prevention of harm caused by SHS to children
and non-smokers should be extended to include smokers.
More research is needed to examine whether SHS can have
more serious health effects such as lung cancer and heart
disease on smokers, as SHS can cause such diseases in non-
smokers. In smoking surveys, both smokers and non-
smokers should be asked about SHS exposures in the same
standard way. Biochemical tests which can separate exposure
to the toxic substances due to active smoking and passive
smoking would be useful (but not yet available) to quantify
the two exposures so that the two effects can be measured
separately. We recognise that the best evidence that SHS can
cause acute respiratory symptoms would have to come from
experiments unethical by any criteria, involving exposure of
What this paper adds
In non-smokers, secondhand smoke (SHS) exposure has
been shown to be a causal factor for heart disease, other
cardiovascular abnormalities and lung cancer in adults, and
respiratory ill health and cardiovascular abnormalities in
children. Few studies have examined the adverse respiratory
effects of SHS exposure among active smokers.
Smokers experience significant additional risks from SHS
exposures. Strong dose–response relationships are found
between SHS exposures, and respiratory symptoms and
recent health care utilisation in active smokers.
The results of this study suggest that SHS exposure can also
harm active smokers. These findings have important implica-
tions for the design and provision of smoking booths in
restaurants, airports and other venues, in which concentra-
tions of SHS are invariably high.
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smokers, while they are not smoking, to SHS in a gas chamber.
However, it is difficult to envisage that if such experiments were
done, the smokers would not feel any discomfort andwould not
report any symptoms after exposure to SHS, which can cause
lung cancer, heart disease, and other health problems.
Under the existing legislation in Hong Kong, smoking is
prohibited in some public indoor premises, such as cinemas,
supermarkets, and shopping malls, but is allowed in most
indoor workplaces, such as restaurants. In May 2005, the
government proposed new legislation that the current ban
should be extended to all indoor spaces, including restau-
rants, bars, and karaokes. The results of the present study
provide a strong argument against the provision of separately
ventilated areas because smokers in designated smoking
areas are exposed to high levels of secondhand smoke which
will cause additional harm to their health. Instead, the only
effective public health approach is to impose a complete ban
without exception or special provision.
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